• APREMILAST CHEMBL514800 FDA ApprovedImmunotherapy

    Alternate Names:

    Apremilast
    CC-10004
    608141-41-9
    11561674
    N-{2-[(1S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-(METHYLSULFONYL)ETHYL]-1,3-DIOXO-2,3-DIHYDRO-1H-ISOINDOL-4-YL}ACETAMIDE
    N-[2-[(1S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-1,3-DIOXOISOINDOL-4-YL]ACETAMIDE
    ACETAMIDE, N-(2-((1S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-(METHYLSULFONYL)ETHYL)- 2,3-DIHYDRO-1,3-DIOXO-1H-ISOINDOL-4-YL)-
    666854-78-0
    (S)-N-{2-[1-(3-ETHOXY-4-METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL]-1,3-DIOXO-2,3-DIHYDRO-1H-ISOINDOL-4-YL}-ACETAMIDE
    (+)-N-(2-((1S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-(METHYLSULFONYL)ETHYL)-1,3-DIOXO- 2,3-DIHYDRO-1H-ISOINDOL-4-YL)ACETAMIDE
    UNII-N5UK68MGDZ COMPONENT IMOZEMNVLZVGJZ-QGZVFWFLSA-N
    S-7765
    D08860
    Y0437
    AB0093139
    BCP0726000109
    KB-74720
    HY-12085
    HE224053
    BC600507
    AK151389
    AJ-84147
    FK-0727
    CS-0671
    BCP9000311
    AKOS016339660
    ZINC30691736
    BDBM50248919
    AOB87775
    CAS:608141-41-9;APREMILAST
    MOLPORT-023-219-158
    IMOZEMNVLZVGJZ-QGZVFWFLSA-N
    QCR-202
    C22H24N2O7S
    GTPL7372
    SCHEMBL302992
    APREMILAST (CC-10004)
    APREMILAST/CC 10004/
    APREMILAST [USAN:INN]
    OTEZLA (TN)
    APREMILAST (USAN)
    OTEZIA
    OTEZLAREG
    APREMILASTUM
    (S)-N-(2-(1-(3-ETHOXY-4-METHOXYPHENYL)-2-(METHYLSULFONYL)ETHYL)-1,3-DIOXOISOINDOLIN-4-YL)ACETAMIDE
    UP7QBP99PN
    UNII-UP7QBP99PN
    CHEBI:78540
    CC10004
    CC 10004
    OTEZLA
    DCL000699
    CHEBI:558773
    50086920
    CID11561674
    N-[2-[1-(3-ETHOXY-4-METHOXY-PHENYL)-2-METHYLSULFONYL-ETHYL]-1,3-DIOXO-ISOINDOL-4-YL]ACETAMIDE
    DB05676
    CAPRIDINE-BETA
    DCL000077
    178103944
    7372

    Drug Info:

    Drug Categories chemical actions and uses
    Drug Categories therapeutic uses
    Drug Categories sensory system agents
    Drug Categories selective immunosuppressants
    Drug Categories piperidones
    Drug Categories piperidines
    Drug Categories physiological effects of drugs
    Drug Categories phthalimides
    Drug Categories phthalic acids
    Drug Categories pharmacologic actions
    Drug Categories peripheral nervous system agents
    Drug Categories organic chemicals
    Drug Categories isoindoles
    Drug Categories immunosuppressive agents
    Drug Categories imides
    Drug Categories heterocyclic compounds, 2-ring
    Drug Categories heterocyclic compounds, 1-ring
    Drug Categories heterocyclic compounds
    Drug Categories cytochrome p-450 cyp3a4 substrates
    Drug Categories central nervous system agents
    Drug Categories carboxylic acids
    Drug Categories antirheumatic agents
    Drug Categories antineoplastic and immunomodulating agents
    Drug Categories anti-inflammatory agents, non-steroidal
    Drug Categories anti-inflammatory agents
    Drug Categories analgesics, non-narcotic
    Drug Categories analgesics
    Drug Categories acids, carbocyclic
    Drug Groups investigational
    Drug Groups approved
    Drug Type small molecule
    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications antiinflammatory agent, DMARD, antipsoriatic
    (3 More Sources)